A kava cream built to challenge the category leaders
Due in November to December 2026.
At a glance
- Cream
- TGA-listed medicine
- Traditional Pacific kava
- Challenger to the category leaders
The brand
A founder-led Australian pain relief brand built on a traditional Pacific Island ingredient, with international distribution interest ahead of launch.
The challenge
A TGA-listed pain relief cream that pairs kava with proven ingredients, matches the category's leading creams on formula and price, feels non-greasy, doesn't stain, and comes in a pack older users can open easily.
What we built
The formula and R&D samples, the claims evidence, the TGA listing (updated after a preservative change), the stability program, the product specification and the label.
Manufacturing and delivery
We're managing manufacturing now, including the tube supply, through to delivery.
Where it stands
- Due in November to December 2026.
“I've got the first batch and I love them.”
Related case studies
Related case studies
A hair range in recycled packaging
Both products delivered in 2024 and 2025.
Read the story →
Signed brief to dispatch in under six months
5.8 months from signed brief to dispatch
Read the story →
From a first product to a national pharmacy rollout
About eight months from formulation to dispatch
Read the story →Fifteen minutes on your pipeline. No deck, no obligation.
